4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-030002
President and CEO acquired 30,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2022-03-01 | Grant or award | +30,250 | 214,710 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2022-03-01 | Grant or award · Stock Option (Right to Buy) | +181,500 | 181,500 | D: show line 2 in the form |
Loading xslF345X03/tm228284d1_4seq1.xml…